Moreover, differences in the relative importance of aetiological factors between the two tumour types are reflected at the molecular level – activating mutations of BRAF are almost universal in cutaneous melanomas but not in uveal tumours (Davies et al, 2002; Cohen et al, 2003; Edmunds et al, 2003). The gene discussed is BRAF; the disease is cutaneous melanoma.